Norio-Olegario Consultants, Inc.

20/05/2026

𝗔 𝗟𝗼𝗻𝗴 𝗪𝗲𝗲𝗸𝗲𝗻𝗱 𝗶𝘀 𝗪𝗮𝘃𝗶𝗻𝗴 𝗳𝗼𝗿 𝗼𝘂𝗿 𝗸𝗮-𝗕𝗮𝗻𝗴𝘀𝗮𝗺𝗼𝗿𝗼! 👋🏼

Pursuant to the Bangsamoro Holidays Act (BAA No. 39), the entire Bangsamoro region will observe the following holidays from May 26 to 28, 2026:

• May 26 (Tuesday): Day of Arafah (Special Non-Working Holiday)

• May 27 (Wednesday): Eid’l Adha (Regular Non-Working Holiday)

• May 28 (Thursday): 1st Day of Tashriq (Special Non-Working Holiday)

Please note that May 25 (Monday) remains a regular working day for all offices. Additionally, for offices on a Four-Day Compressed Workweek (Monday–Thursday), since Friday is already your regular rest day, your long weekend will effectively extend from Tuesday, May 26, all the way until Sunday, May 31, 2026.

Plan your schedules accordingly, ka-Bangsamoro! 🧳

15/05/2026

14/05/2026

***FDA Advisory No.2026-0596 || Endorsement of Updates on the List of VAT-Exempt Drugs and Medicines***

In line with Philippine government’s continuing efforts to ensure accessible and affordable healthcare, the Food and Drug Administration (FDA) issues this Advisory to inform the public of the latest updates on the List of Value-Added Tax (VAT) Exempt Drugs and Medicines, pursuant to the implementation of Republic Act No. 11534, also known as the Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.

See more:-> https://tinyurl.com/ead696tn

29/04/2026

20/04/2026

Training on Good Manufacturing Practice for Food Manufacturers and Traders (GMP-FMT)

This webinar will provide the methods, identify the equipment, enumerate the facilities, and determine the controls for producing processed food as stated in the Current GMP for Food, as published in A.O. 153 s 2004..

Join our webinar on 23-24 July 2026 from 8:00 am to 5:00 pm via Google Meet
Registration fee: Php 800.00
Register through this link: bit.ly/4stACmu

Maximum of 1000 participants
First-come-first-served basis

All successful registrants/applicants shall wait for the confirmation email from the FDA Academy for the issuance of Course Assessment Slip (CAS) and payment instruction pursuant to FDA Circular 2023-010.

Payments made without the corresponding CAS from the FDA Academy shall be forfeited.

05/02/2026

***Announcement || NOTICE OF PUBLIC CONSULTATION***

The Food and Drug Administration (FDA) is committed to safeguarding public health through efficient, transparent, and sustainable regulation of health products. In line with its
modernization agenda and its mandate under Republic Act (RA) No. 9711, also known as the “FDA Act of 2009,” the FDA issued Administrative Order (AO) No. 2024-0016, entitled “Implementing Guidelines on the New Schedule of Fees and Charges of the FDA,” which provides an updated schedule of fees and charges to reflect current operational requirements and support service improvements. The revision of FDA fees and charges aims to ensure that safe and high-quality health products remain accessible to the public by strengthening the FDA’s capacity to regulate and support the health sector.

Read more:-> https://tinyurl.com/mryh7pj3

19/12/2025

17/12/2025

****Draft for Comments || Guidelines on the Use of Acceptable Nutrition and Health Claims in the Labeling, Advertisement, Sponsorships, Promotions, and Other Marketing Activities of Prepackaged Processed Food Products****

All comments shall be sent to [email protected]. The deadline for submission of comments is on 15 January 2026.

I. BACKGROUND

The 1987 Constitution, under Article II, Section 15, declares the State’s policy to protect and promote the people’s right to health and to foster health consciousness. Further, Article XIII, Section 12 mandates the establishment and maintenance of an effective food and drug regulatory system that undertakes appropriate health services, manpower development, and research responsive to national health needs and concerns.

See more:-> https://tinyurl.com/y43243fw

13/12/2025

***FDA Advisory No.2025-1478 || PUBLIC HEALTH ADVISORY: BEWARE OF UNREGISTERED ALCOHOLIC BEVERAGES THIS HOLIDAY SEASON ***

The Food and Drug Administration (FDA) reminds the public to exercise vigilance and caution when purchasing and consuming alcoholic beverages this holiday season.

Read more:-> https://tinyurl.com/2nz2anja

12/12/2025

****Draft for Comments || Operational Procedures on the Application for Sales Promotion Permit with the Food and Drug Administration
****

Deadline for commenting: 12 January 2026
All comments shall be submitted in MSWord and pdf file formats to [email protected] using the provided, "Template for Comments".

I. RATIONALE

Republic Act No. 9711 otherwise known as the “Food and Drug Administration Act of 2009” promulgates the strengthening of the Food and Drug Administration (FDA) in the regulation of health products and products that have effect on health, such as promotion activities involving such products under the jurisdiction of the FDA. The four Centers of the FDA namely, Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research, Center for Device Regulation Radiation Health and Research, Center for Food Regulation and Research, and Center for Drug Regulation and Research, through the guiding principles enshrined in the Implementing Rules and Regulations (IRR) of RA No. 9711 are mandated to prescribe policies, standards, regulations, and guidelines with respect to information, advertisements, promotions, sponsorship, and other marketing instruments or activities about the FDA covered health products (Art.II.A.Sec.2.q). Additionally, RA No. 7394, otherwise known as the “Consumer Act of the Philippines” mandates the Department of Health through the FDA to protect the consumer from misleading advertisements and fraudulent sales promotion practices with respect to foods, drugs, cosmetics, devices, and hazardous substances (Ch.VI).

See more:-> https://tinyurl.com/z3f359tu